Tweet
Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical ... MarketWatch MARLBOROUGH, Mass., Aug. 30, 2014 /PRNewswire/ -- Boston Scientific has released the primary endpoint results from its NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) clinical trial, the first and only randomized sham-controlled clinical trial ... Boston Scientific nerve device no help in heart failure studyYahoo News all 7 news articles » |
More...